Carrie Leigh - 01 Nov 2024 Form 3 Insider Report for UTAH MEDICAL PRODUCTS INC (UTMD)

Reporting relationship: Director
Issuer ticker: UTMD
Reported as of: 01 Nov 2024
Net transaction value: $0
SEC form: 3
Accepted by SEC: 12 Nov 2024, 09:51:55 UTC
Source filing: View source filing
Reporting owner signature: /s/Carrie Leigh

Key filing fact

Carrie Leigh filed Form 3 for UTAH MEDICAL PRODUCTS INC (UTMD) on 12 Nov 2024.

Key facts

This page summarizes Carrie Leigh's Form 3 filing for UTAH MEDICAL PRODUCTS INC (UTMD).
0 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 12 Nov 2024, 09:51.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

UTMD holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 51
Date: 01 Nov 2024
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

UTMD holding Derivative

Stock Option - Right to Buy

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Nov 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,000
Exercise price: $64.09
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Option will vest 25% on 10/01/2025, and an additional 6.25% on 01/01/2026 and the first day of each calendar quarter thereafter. Fully exercisable on 10/01/2028.